Home/Pipeline/VV-14295

VV-14295

Geographic atrophy (dry AMD)

Phase 1Active

Key Facts

Indication
Geographic atrophy (dry AMD)
Phase
Phase 1
Status
Active
Company

About Everads Therapy

Platform company delivering suprachoroidal injections to improve retinal disease treatments.

View full company profile

Therapeutic Areas